General Information of Drug Transporter (DT)
DT ID DTD0292 Transporter Info
Gene Name SLC35B1
Transporter Name UDP-galactose transporter-related protein 1
Gene ID
10237
UniProt ID
P78383
Post-Translational Modification of This DT
Overview ofSLC35B1 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Phosphorylation X-Phosphorylation X: Amino Acid

Phosphorylation

  Proline

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon1

. [1]

Role of PTM

Potential impacts

Modified Residue

Proline

Modified Location

15

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC35B1 Proline 15 has the potential to affect its expression or activity.

  PTM Phenomenon2

. [1]

Role of PTM

Potential impacts

Modified Residue

Proline

Modified Location

15

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC35B1 Proline 15 has the potential to affect its expression or activity.

  Tyrosine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon1

Have the potential to influence SLC35B1 [2]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

27

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC35B1 Tyrosine 27 has the potential to affect its expression or activity.
References
1 BioMuta and BioXpress: mutation and expression knowledgebases for cancer biomarker discovery. Nucleic Acids Res. 2018;46(D1):D1128-D1136.
2 Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 Jun 2;534(7605):55-62.

If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.